PD-1 expression on TAMs decreases phagocytic potency against tumor cells, whereas PD-1–PD-L1 blockade significantly increases phagocytosis by PD-1+ macrophages and reduces tumor growth in vivo [150]. The gene discussed is PDCD1; the disease is neoplasm.